Tommie Haywood, MD
Gastroenterology · Decatur, GANPI 1811979339
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 30.7% of the total.
Across 253 payments — averaging $19.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$526
- Johnson & Johnson$509
- Takeda Pharmaceuticals U.S.A., Inc.$444
- Regeneron Healthcare Solutions, Inc.$300
- Merck$244
- plus $1K from 22 others
What the payments were for
- Food & beverage$4,66297%
- Education$1673%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 80 | $1,483 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 29 | $526 |
| Johnson & Johnson | 30 | $509 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $444 |
| Regeneron Healthcare Solutions, Inc. | 9 | $300 |
| Merck | 13 | $244 |
| Madrigal Pharmaceuticals | 9 | $240 |
| Braintree Laboratories, Inc. | 18 | $180 |
| Lilly USA, LLC | 6 | $131 |
| Ironwood Pharmaceuticals, Inc | 7 | $125 |
| Pfizer | 6 | $118 |
| Redhill Biopharma Inc. | 5 | $85 |
| Ipsen Biopharmaceuticals, Inc | 3 | $71 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 2 | $38 |
| Boehringer Ingelheim | 2 | $37 |
| Sanofi | 1 | $36 |
| Ferring Pharmaceuticals Inc. | 1 | $26 |
| Intercept Pharmaceuticals, Inc. | 1 | $20 |
| Aimmune Therapeutics, Inc. | 1 | $20 |
| Biocon Biologics Inc | 1 | $20 |
| Ardelyx, Inc. | 1 | $19 |
| Bristol Myers Squibb | 1 | $19 |
| AMAG Pharmaceuticals, Inc. | 1 | $18 |
| Organon | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Olympus America Inc. | 1 | $16 |
| Evoke Pharma, Inc. | 1 | $14 |
How this compares
$4,829 in reported general payments places this provider in the 55th percentile of 492 gastroenterology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 149 | $10,351 |
| Omeprazole | 57 | $405 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 25 | $385 |
| Clarithromycin | 11 | $279 |
| Ondansetron OdtOndansetron | 30 | $70 |
| Amoxicillin | 12 | $27 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Decatur
- Nitin GuptaAtlanta$1.1M
- Cynthia RudertAtlanta$720K
- Douglas WolfAtlanta$668K
- Kavita KongaraAtlanta$492K
- Girish AnandAtlanta$425K
- Satish RaoAugusta$335K
- Roshan ShresthaAtlanta$317K
- Hetal KarsanAtlanta$314K
- Aja McCutchenWinder$310K
- Bruce SalzbergSuwanee$275K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.